{"id":22955,"date":"2023-10-27T00:22:00","date_gmt":"2023-10-27T00:22:00","guid":{"rendered":"https:\/\/www.prnasia.com\/story\/archive\/4250050_AE50050_0"},"modified":"2023-10-27T00:22:00","modified_gmt":"2023-10-27T00:22:00","slug":"everest-medicines-announces-poster-presentation-at-asn-kidney-week-on-nefecon-chinese-patient-data-and-to-hold-conference-calls","status":"publish","type":"post","link":"https:\/\/transmediavictoria.net.au\/?p=22955","title":{"rendered":"Everest Medicines Announces Poster Presentation at ASN Kidney Week on Nefecon\u00ae Chinese Patient Data and to Hold Conference Calls"},"content":{"rendered":"\n<p><span class=\"xn-location\">SHANGHAI<\/span>, <span class=\"xn-chron\">Oct. 27, 2023<\/span> \/PRNewswire\/ &#8212; Everest Medicines (HKEX 1952.HK, &quot;Everest&quot;, or the &quot;Company&quot;), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, today announced that it will make a late-breaking poster presentation at the upcoming American Society of Nephrology (ASN) Kidney Week 2023 on Nefecon&reg; Chinese patient data. The company will hold conference calls after the presentation in English and Mandarin on <span class=\"xn-chron\">November 3, 2023<\/span> Beijing Time.<\/p>\n<p><b><u>Late-Breaking Poster Presentation Details:<\/u><\/b><\/p>\n<p><b>Title:&nbsp;<\/b>Long-term renal benefit with Nefecon in Chinese patients with primary immunoglobulin A nephropathy: 2-year NefIgArd trial results<\/p>\n<p><b>Date and Time:&nbsp;<\/b><span class=\"xn-chron\">Thursday, November 2<\/span>, <span class=\"xn-chron\">10:00 a.m.<\/span> \u2013 <span class=\"xn-chron\">12:00 p.m. ET<\/span><\/p>\n<p><b>Session:&nbsp;<\/b>Late-Breaking Posters [LB-PO]&nbsp;<\/p>\n<p><b>Presentation No.:&nbsp;<\/b>TH-PO1123 (Abstract 3969868)<\/p>\n<p><b>Presentation Venue:&nbsp;<\/b>Exhibit Halls B\u2013D (<span class=\"xn-location\">Pennsylvania<\/span> Convention Center)<\/p>\n<p><b><u>Conference Call Details:<\/u><\/b><\/p>\n<p>For English Session:<\/p>\n<p>Time: <span class=\"xn-chron\">9:00 AM<\/span> Beijing Time, <span class=\"xn-chron\">Friday, November 3, 2023<\/span> \/ <span class=\"xn-chron\">9:00 PM ET<\/span>, <span class=\"xn-chron\">Thursday, November 2, 2023<\/span><\/p>\n<p>Pre-Registration Link: <a href=\"https:\/\/linkprotect.cudasvc.com\/url?a=https%3a%2f%2fwww.acecamptech.com%2feventDetail%2f60504537&amp;c=E,1,vowHxNM0_6mVZ0Jl0xLTuTCtmxagxJqcIXPdGg62zpMpi2o_hQnHOmNbF7I2NWnoxJ4JMaEHsJN6JQ4ln7-w00xJDXlIHNPj8tyxY2zwyzZcKjNYBw,,&amp;typo=1&amp;ancr_add=1\" target=\"_blank\" rel=\"nofollow noopener\">https:\/\/www.acecamptech.com\/eventDetail\/60504537<\/a><\/p>\n<p>Webcast Link: <a href=\"https:\/\/linkprotect.cudasvc.com\/url?a=https%3a%2f%2fwww.acecamptech.com%2fmeeting_live%2f70506314%2f5517%3fevent_id%3d60504537&amp;c=E,1,6GcccG3o2vVszNf-bdeBxG1GB_jHkLKfpL9E77dldFrcKZ1gaLO-Q3nprsvTC19AL3WSOqsi06EWiwmORvujVnes5t_Am7jIqLkPbyTzb5suXuNG2mtkMg,,&amp;typo=1&amp;ancr_add=1\" target=\"_blank\" rel=\"nofollow noopener\">https:\/\/www.acecamptech.com\/meeting_live\/70506314\/5517?event_id=60504537<\/a><\/p>\n<p>Alternatively, participants may dial in to the conference call using below dial-in information:<\/p>\n<div>\n<table border=\"0\" cellspacing=\"0\" cellpadding=\"1\" class=\"prnbcc\">\n<tbody>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\" nowrap=\"nowrap\">\n<p class=\"prnml4\"><span class=\"prnews_span\">United States:<\/span><\/p>\n<\/td>\n<td class=\"prngen3\" colspan=\"1\" rowspan=\"1\" nowrap=\"nowrap\">\n<p class=\"prnml4\"><span class=\"prnews_span\">+1 646 2543594 (EN)<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\" nowrap=\"nowrap\">\n<p class=\"prnml4\"><span class=\"prnews_span\">Mainland China: <\/span><\/p>\n<\/td>\n<td class=\"prngen5\" colspan=\"1\" rowspan=\"1\" nowrap=\"nowrap\">\n<p class=\"prnml4\"><span class=\"prnews_span\">+86 10 58084166 (EN)<\/span><\/p>\n<p class=\"prnml4\"><span class=\"prnews_span\">+86 10 58084199 (CN)<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\" nowrap=\"nowrap\">\n<p class=\"prnml4\"><span class=\"prnews_span\">Hong Kong: <\/span><\/p>\n<\/td>\n<td class=\"prngen5\" colspan=\"1\" rowspan=\"1\" nowrap=\"nowrap\">\n<p class=\"prnml4\"><span class=\"prnews_span\">+852 30051313 (EN)<\/span><\/p>\n<p class=\"prnml4\"><span class=\"prnews_span\">+852 30051355 (CN)<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\" nowrap=\"nowrap\">\n<p class=\"prnml4\"><span class=\"prnews_span\">United Kingdom:<\/span><\/p>\n<\/td>\n<td class=\"prngen5\" colspan=\"1\" rowspan=\"1\" nowrap=\"nowrap\">\n<p class=\"prnml4\"><span class=\"prnews_span\">+44 20 76600166 (EN)<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\" nowrap=\"nowrap\">\n<p class=\"prnml4\"><span class=\"prnews_span\">International:<\/span><\/p>\n<\/td>\n<td class=\"prngen6\" colspan=\"1\" rowspan=\"1\" nowrap=\"nowrap\">\n<p class=\"prnml4\"><span class=\"prnews_span\">+1 866 6363243<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\" nowrap=\"nowrap\">\n<p class=\"prnml4\"><span class=\"prnews_span\">Password:<\/span><\/p>\n<\/td>\n<td class=\"prngen6\" colspan=\"1\" rowspan=\"1\" nowrap=\"nowrap\">\n<p class=\"prnml4\"><span class=\"prnews_span\">388208<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n<p>For Mandarin Session:<\/p>\n<p>Time: <span class=\"xn-chron\">10:00 AM<\/span> Beijing Time, <span class=\"xn-chron\">Friday, November 3, 2023<\/span> \/ <span class=\"xn-chron\">10:00 PM ET<\/span>, <span class=\"xn-chron\">Thursday, November 2, 2023<\/span><\/p>\n<p>Webcast Link: <a href=\"https:\/\/s.comein.cn\/AfPNw\" target=\"_blank\" rel=\"nofollow noopener\">https:\/\/s.comein.cn\/AfPNw<\/a><\/p>\n<p>Alternatively, participants may dial into the conference call using below dial-in information:<\/p>\n<div>\n<table border=\"0\" cellspacing=\"0\" cellpadding=\"1\" class=\"prnbcc\">\n<tbody>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\" nowrap=\"nowrap\">\n<p class=\"prnml4\"><span class=\"prnews_span\">Mainland China:<\/span><\/p>\n<\/td>\n<td class=\"prngen3\" colspan=\"1\" rowspan=\"1\" nowrap=\"nowrap\">\n<p class=\"prnml4\"><span class=\"prnews_span\">+86-4001888938<\/span><\/p>\n<p class=\"prnml4\"><span class=\"prnews_span\">+86-01053827720<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\" nowrap=\"nowrap\">\n<p class=\"prnml4\"><span class=\"prnews_span\">Taiwan:<\/span><\/p>\n<\/td>\n<td class=\"prngen5\" colspan=\"1\" rowspan=\"1\" nowrap=\"nowrap\">\n<p class=\"prnml4\"><span class=\"prnews_span\">+886-277031747<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\" nowrap=\"nowrap\">\n<p class=\"prnml4\"><span class=\"prnews_span\">United States:<\/span><\/p>\n<\/td>\n<td class=\"prngen5\" colspan=\"1\" rowspan=\"1\" nowrap=\"nowrap\">\n<p class=\"prnml4\"><span class=\"prnews_span\">+1-2025524791<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\" nowrap=\"nowrap\">\n<p class=\"prnml4\"><span class=\"prnews_span\">United Kingdom<\/span><\/p>\n<\/td>\n<td class=\"prngen5\" colspan=\"1\" rowspan=\"1\" nowrap=\"nowrap\">\n<p class=\"prnml4\"><span class=\"prnews_span\">+44-2034816288<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\" nowrap=\"nowrap\">\n<p class=\"prnml4\"><span class=\"prnews_span\">Singapore:<\/span><\/p>\n<\/td>\n<td class=\"prngen5\" colspan=\"1\" rowspan=\"1\" nowrap=\"nowrap\">\n<p class=\"prnml4\"><span class=\"prnews_span\">+65-31586120<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\" nowrap=\"nowrap\">\n<p class=\"prnml4\"><span class=\"prnews_span\">Hong Kong:<\/span><\/p>\n<\/td>\n<td class=\"prngen5\" colspan=\"1\" rowspan=\"1\" nowrap=\"nowrap\">\n<p class=\"prnml4\"><span class=\"prnews_span\">+852-57006920<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\" nowrap=\"nowrap\">\n<p class=\"prnml4\"><span class=\"prnews_span\">Password:<\/span><\/p>\n<\/td>\n<td class=\"prngen6\" colspan=\"1\" rowspan=\"1\" nowrap=\"nowrap\">\n<p class=\"prnml4\"><span class=\"prnews_span\">157383<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n<p>The replay of English session will be available shortly after the call and can be accessed by visiting the Company&#8217;s website at&nbsp;<a href=\"http:\/\/www.everestmedicines.com\/\" target=\"_blank\" rel=\"nofollow noopener\">http:\/\/www.everestmedicines.com<\/a>.<\/p>\n<p><b>About Everest Medicines<\/b><\/p>\n<p>Everest Medicines is a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Asian markets. The management team of Everest Medicines has deep expertise and an extensive track record from both leading global pharmaceutical companies and local Chinese pharmaceutical companies in high-quality clinical development, regulatory affairs, CMC, business development and operations. Everest Medicines has built a portfolio of potentially global first-in-class or best-in-class molecules, many of which are in late-stage clinical development. The Company&#8217;s therapeutic areas of interest include cardio-renal diseases, autoimmune disorders, and infectious diseases. For more information, please visit its website at <a href=\"https:\/\/www.everestmedicines.com\/\" target=\"_blank\" rel=\"nofollow noopener\">www.everestmedicines.com<\/a>.&nbsp;<\/p>\n<p><b>Forward-Looking Statements:<\/b><\/p>\n<p>This news release may make statements that constitute forward-looking statements, including descriptions regarding the intent, belief or current expectations of the Company or its officers with respect to the business operations and financial condition of the Company, which can be identified by terminology such as &quot;will,&quot; &quot;expects,&quot; &quot;anticipates,&quot; &quot;future,&quot; &quot;intends,&quot; &quot;plans,&quot; &quot;believes,&quot; &quot;estimates,&quot; &quot;confident&quot; and similar statements. Such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, or other factors, some of which are beyond the control of the Company and are unforeseeable. Therefore, the actual results may differ from those in the forward-looking statements as a result of various factors and assumptions, such as future changes and developments in our business, competitive environment, political, economic, legal and social conditions. The Company or any of its affiliates, directors, officers, advisors or representatives has no obligation and does not undertake to revise forward-looking statements to reflect new information, future events or circumstances after the date of this news release, except as required by law.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>SHANGHAI, Oct. 27, 2023 \/PRNewswire\/ &#8212; Everest Medicines (HKEX 1952.HK, &quot;Everest&quot;, or the &quot;Company&quot;), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, today announced that it will make a late-breaking poster presentation at the upcoming American Society of Nephrology (ASN) Kidney Week 2023 on Nefecon&reg; Chinese patient data. [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-22955","post","type-post","status-publish","format-standard","hentry","category-business-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Everest Medicines Announces Poster Presentation at ASN Kidney Week on Nefecon\u00ae Chinese Patient Data and to Hold Conference Calls - My Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/transmediavictoria.net.au\/?p=22955\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Everest Medicines Announces Poster Presentation at ASN Kidney Week on Nefecon\u00ae Chinese Patient Data and to Hold Conference Calls - My Blog\" \/>\n<meta property=\"og:description\" content=\"SHANGHAI, Oct. 27, 2023 \/PRNewswire\/ &#8212; Everest Medicines (HKEX 1952.HK, &quot;Everest&quot;, or the &quot;Company&quot;), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, today announced that it will make a late-breaking poster presentation at the upcoming American Society of Nephrology (ASN) Kidney Week 2023 on Nefecon&reg; Chinese patient data. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/transmediavictoria.net.au\/?p=22955\" \/>\n<meta property=\"og:site_name\" content=\"My Blog\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-27T00:22:00+00:00\" \/>\n<meta name=\"author\" content=\"admin_tony\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin_tony\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=22955#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=22955\"},\"author\":{\"name\":\"admin_tony\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"headline\":\"Everest Medicines Announces Poster Presentation at ASN Kidney Week on Nefecon\u00ae Chinese Patient Data and to Hold Conference Calls\",\"datePublished\":\"2023-10-27T00:22:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=22955\"},\"wordCount\":585,\"articleSection\":[\"Business News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=22955\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=22955\",\"name\":\"Everest Medicines Announces Poster Presentation at ASN Kidney Week on Nefecon\u00ae Chinese Patient Data and to Hold Conference Calls - My Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\"},\"datePublished\":\"2023-10-27T00:22:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=22955#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=22955\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=22955#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Everest Medicines Announces Poster Presentation at ASN Kidney Week on Nefecon\u00ae Chinese Patient Data and to Hold Conference Calls\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\",\"name\":\"My Blog\",\"description\":\"My WordPress Blog\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\",\"name\":\"admin_tony\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"caption\":\"admin_tony\"},\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?author=8\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Everest Medicines Announces Poster Presentation at ASN Kidney Week on Nefecon\u00ae Chinese Patient Data and to Hold Conference Calls - My Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/transmediavictoria.net.au\/?p=22955","og_locale":"en_US","og_type":"article","og_title":"Everest Medicines Announces Poster Presentation at ASN Kidney Week on Nefecon\u00ae Chinese Patient Data and to Hold Conference Calls - My Blog","og_description":"SHANGHAI, Oct. 27, 2023 \/PRNewswire\/ &#8212; Everest Medicines (HKEX 1952.HK, &quot;Everest&quot;, or the &quot;Company&quot;), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, today announced that it will make a late-breaking poster presentation at the upcoming American Society of Nephrology (ASN) Kidney Week 2023 on Nefecon&reg; Chinese patient data. [&hellip;]","og_url":"https:\/\/transmediavictoria.net.au\/?p=22955","og_site_name":"My Blog","article_published_time":"2023-10-27T00:22:00+00:00","author":"admin_tony","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin_tony","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/transmediavictoria.net.au\/?p=22955#article","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/?p=22955"},"author":{"name":"admin_tony","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"headline":"Everest Medicines Announces Poster Presentation at ASN Kidney Week on Nefecon\u00ae Chinese Patient Data and to Hold Conference Calls","datePublished":"2023-10-27T00:22:00+00:00","mainEntityOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=22955"},"wordCount":585,"articleSection":["Business News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/transmediavictoria.net.au\/?p=22955","url":"https:\/\/transmediavictoria.net.au\/?p=22955","name":"Everest Medicines Announces Poster Presentation at ASN Kidney Week on Nefecon\u00ae Chinese Patient Data and to Hold Conference Calls - My Blog","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/#website"},"datePublished":"2023-10-27T00:22:00+00:00","author":{"@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"breadcrumb":{"@id":"https:\/\/transmediavictoria.net.au\/?p=22955#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/transmediavictoria.net.au\/?p=22955"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/transmediavictoria.net.au\/?p=22955#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/transmediavictoria.net.au\/"},{"@type":"ListItem","position":2,"name":"Everest Medicines Announces Poster Presentation at ASN Kidney Week on Nefecon\u00ae Chinese Patient Data and to Hold Conference Calls"}]},{"@type":"WebSite","@id":"https:\/\/transmediavictoria.net.au\/#website","url":"https:\/\/transmediavictoria.net.au\/","name":"My Blog","description":"My WordPress Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/transmediavictoria.net.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7","name":"admin_tony","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","caption":"admin_tony"},"url":"https:\/\/transmediavictoria.net.au\/?author=8"}]}},"_links":{"self":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/22955","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=22955"}],"version-history":[{"count":0,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/22955\/revisions"}],"wp:attachment":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=22955"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=22955"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=22955"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}